Showing 1216 Results
Health Spending: Tackling the Big Issues
The Health Affairs and National Pharmaceutical Council event, “Health Spending: Tackling the Big Issues,” convened a crowd of more than 450 to ask critical questions about how the United States…
Peer-reviewed Journal Editors' Views on Real-world Evidence
A study published in the International Journal of Technology Assessment in Health Care reveals that real-world evidence is considered valuable by the editors of peer-reviewed journals—if it meets…
Journal Editors Value Real-World Evidence—With Conditions
New research from the Department of Pharmaceutical Health Services Research at the University of Maryland School of Pharmacy and the National Pharmaceutical Council reveals that real-world evidence …
Tackling the Big Issues in Health Spending
The Health Affairs and National Pharmaceutical Council event, “Health Spending: Tackling the Big Issues,” convened a crowd of more than 450 to ask critical questions about how the United States…
NPC in AJPB: Having a Broader Conversation About Health Care Spending
In his latest column for the American Journal of Pharmacy Benefits, National Pharmaceutical Council President Dan Leonard argues it’s time for us to have a broader, more honest conversation…
A Precision Paradigm for Value Assessment: How Frameworks Can Account for Personalized Medicine to Inform Payers, Providers, Innovators and Patients
Personalized Medicine Coalition Senior Vice President of Science Policy Daryl Pritchard, PhD, explores personalized medicine and value assessment frameworks.
NPC in Chain Drug Review: Pharmacy Outlook 2018
NPC President Dan Leonard explores value- and outcomes-based contracts, innovative benefit design, value assessment frameworks and more in his latest commentary for Chain Drug Review.
Biopharma Innovation Just Part Of Health Care Equation
Biopharma discoveries are changing people's lives in ways we didn't know were possible just a decade ago. As the industry's science continually expands the treatment frontier, the business of health…
Where Are They Now: Checking In With Former NPC Intern Jan Hansen
Jan Hansen, PhD, currently Vice President, Evidence for Access Medical Unit, US Medical Affairs at Genentech, participated in NPC’s pharmaceutical internship program in 1982. Dr. Hansen chatted with…
Insurance Switching and the Mismatch Between the Costs and Benefits of New Technologies
The peer-reviewed study examined the disconnect between the short-term budget impact of a treatment and its downstream effects on payers and society.
Why We Need A Serious Conversation About Health Spending
The government released its annual assessment on health spending in 2016 and the overall spending number came in at $3.3 trillion, up 4.3 percent from 2015. We know the easy fixes aren’t up to the…
NPC in Health Affairs Blog: It’s Time for a Serious Conversation About Health Care Spending
In a blog published today in Health Affairs, National Pharmaceutical Council Chief Science Officer Robert W. Dubois, MD, PhD, noted that a serious conversation among all health care stakeholders is…
NAMI Weighs in on Value Assessment and ICER Engagement
Andrew Sperling, Director of Legislative Advocacy for the National Alliance on Mental Illness (NAMI), caught up with NPC President Dan Leonard to chat about concerns raised by mental health advocates…
Where Are They Now: Checking In With Former NPC Intern Dan Danielson
Dan Danielson, MS, currently a senior clinical manager at Premera Blue Cross, participated in NPC’s pharmaceutical internship program in 1993. Mr. Danielson chatted with us to answer a few questions…
NPC in AJPB: Working Toward Better Value in Prescription Drug Benefits Management
U.S. employers provide a vital link to health care, with more than 56 percent of them offering health insurance for their employees. However, how employers design those health benefits can vary…